31 August 2023 in ScienceRise: Pharmaceutical Science
The aim: development of methodological approaches to assessing the digital maturity of the logistics activity of a pharmaceutical enterprise and elaboration of the proposed methodology on the example of those domestic enterprises that have a developed logistics system and some experience in the implementation of digital technologies in logistics activities. Materials and methods: Research was conducted using databases on the Internet: the European Center for Information Systems Research, the European Medicines Agency, and scientific and metric databases - Scopus, Web of Science. Logical, systematic analysis and synthesis, graphic methods of research, and methods of mathematical and statistical analysis (expert, pair correlation and taxonomic) were used. The results. An analysis of the state of implementation of digital technologies was carried out on the example of domestic pharmaceutical enterprises, which have been the leaders of the pharmaceutical market in recent years. It is substantiated that the assessment of digital maturity is a mandatory prerequisite for the digital transformation of pharmaceutical market entities. The existing models of digital maturity assessment are analyzed, and their shortcomings are identified. Based on this, a methodology for assessing the digital maturity of the logistics activities of pharmaceutical enterprises is proposed. An algorithm for the practical implementation of the methodology for assessing the digital maturity of the logistics activity of pharmaceutical enterprises is proposed. Based on the application of the proposed methodological approaches for assessing digital maturity using the taxonomic method, the calculation of the integral indicator of the level of digital maturity of the logistics activity of domestic pharmaceutical enterprises was carried out. The priorities for the implementation of digital technologies in the logistics activities of pharmaceutical enterprises were determined depending on the degree of their digital maturity. Conclusions. It has been proven that the digital transformation of the logistics activities of pharmaceutical enterprises is a complex process that must consider many factors of the internal and external environment of the pharmaceutical enterprise. It is impossible to form a strategy and make decisions about investing in digital technologies without first assessing your real opportunities and weak points of the enterprise. That is why the assessment of the existing level of digital maturity is an important step on the way to the systematic digitalization of the logistics activities of a pharmaceutical enterprise. The proposed methodical approaches to assessing the digital maturity of the logistics activity of pharmaceutical enterprises will allow to form a holistic view of the real level of digital maturity of a certain enterprise and its deviation from the desired state, determine the priority directions for increasing the level of digital maturity, based on the specifics of the logistics activity of a particular pharmaceutical enterprise, and develop a sound digital strategy to improve the performance of both the individual business and the pharmaceutical supply chain
26 May 2022 in Social Pharmacy in Health Care
Aim. To analyze the current trends in the field of digitalization of pharmaceutical logistics and supply chain management in the context of the coronavirus pandemic and identify factors that hinder the introduction of digital technologies into the activities of pharmaceutical market entities. Materials and methods. To achieve the goal of the study, an analysis of foreign and domestic scientific literature, an expert survey of managers and employees of pharmaceutical companies was conducted. The research methods were abstract-logical, monographic, system and content analysis, expert survey. Results. The relevance of digitalization of pharmaceutical logistics and supply chain management in the context of the coronavirus pandemic has been substantiated. A review of the practice of implementing digital technologies in the activities of domestic pharmaceutical companies has been conducted. According to the expert survey, the problems of introducing digital technologies into the activities of pharmaceutical companies from the point of view of managers and the staff have been identified. The reasons that hinder the process of introducing modern digital technologies into the activities of the domestic pharmaceutical sector in the field of healthcare have been determined. Conclusions. The use of digital technologies is a necessary element of restructuring the information and logistics support for all participants in pharmaceutical supply chains, improving the reliability and quality of their activities and protecting the chains from counterfeit products. This problem is especially relevant in a pandemic when a well-organized and uninterrupted pharmaceutical logistics becomes in many cases an important condition for preserving not only health, but also human life. Therefore, today it is necessary to implement a comprehensive system of measures aimed at increasing the level of digitalization of the pharmaceutical industry, which will contribute to increasing the efficiency of the functioning of pharmaceutical supply chains, as well as improving the reliability and continuity of drug supply to the population of Ukraine.
9 December 2020 in Farmatsevtychnyi zhurnal
The global economic crisis, which is linked to the coronavirus pandemic, has also affected pharmaceutical logistics. Therefore, the improvement of logistics processes within the pharmaceutical supply chain to increase the access to health care to the population in a pandemic becomes especially important. The aim of the work is to study and summarize the main problems of pharmaceutical logistics in a coronavirus pandemic and substantiate the reserves to improve the functioning of pharmaceutical supply chains. To achieve the goal of the study, an analysis of the domestic scientific literature and the current regulatory framework of Ukraine was conducted. It has used abstract-logical, monographic research methods and system analysis, as well as the method of expert survey. Realizing the importance of providing the population with necessary medicines during the pandemic in Ukraine on October 14, 2020, the Law «Changes to the article 19 of the Law of Ukraine "On Medicinal Products" on Electronic Retail Trade in Medicines» of September 17, 2020 № 904-IX has enforced. It has been evaluated the factors influencing the efficiency and coordination of the activities of pharmaceutical supply chain participants. A risk management algorithm for pharmaceutical supply chains has been developed, its structural elements and relationships have been identified. The presented algorithm will allow analyzing and estimating any deviations from the planned parameters in pharmaceutical supply chains on the basis of establishment of system of the corresponding indicators and on the basis of this information to define effective methods to counter the risks. The urgency of the problem of increasing the reliability and safety of domestic pharmaceutical supply chains in a pandemic has proved. It is justified that the introduction of digital technologies will increase the reliability, transparency and quality of business processes in the pharmaceutical supply chains during a pandemic, drastic changes in the pharmaceutical market and low predictability of demand for medicines and medical devices. The main problems of logistics in a pandemic in the domestic pharmaceutical industry are studied. It has established that the narrowest places in the organization of pharmaceutical supply chains are the improper organization of information exchange between pharmaceutical supply chain participants and the insufficient professional level of production interaction of managers. It has established the priority directions of increase of stability and reliability of functioning of pharmaceutical supply chains which is a necessary condition of accessibility of pharmaceutical provision of the population, especially in the conditions of a pandemic.
1 January 2023 in International scientific journal "Internauka". Series: "Economic Sciences"
NPNational University of Pharmacy
National University of Pharmacy
+2
1 January 2023 in International scientific journal "Internauka". Series: "Economic Sciences"
26 May 2022 in Social Pharmacy in Health Care
Aim. To systematize and substantiate the expediency of using personified marketing communications in pharmacy based on a scientific and methodological approach and develop a process model for managing personified marketing communications in pharmacy, which will be useful to pharmaceutical market entities in order to provide the effectiveness of pharmaceutical promotion and interaction with a potential target audience. Materials and methods. To implement the objectives, the methods of content analysis, structural and system analysis, sociological and marketing research, comparative analysis, grouping, and graphical method were used. Results. The expediency of using personified marketing communications in the system of promoting drugs to the Ukrainian pharmaceutical market has been systematized and substantiated, taking into account the foreign experience. The rating of the activity of using personified marketing communications in Ukraine and abroad has been made and compared; the prospects and advantages of their implementation at the Ukrainian market have been identified. A process model for managing personified marketing communications in pharmacy has been developed and proposed. Conclusions. Personified marketing communications provide that the subjects of the pharmaceutical market concentrate their communicative efforts on the target audience; this further gives them the opportunity to save money and minimize unnecessary investment in the promotion of drugs. The proposed process model of management of personified marketing communications in pharmacy will contribute to improving the quality of pharmaceutical care to the country’s population.